Table 3 Five-year disease-specific survival stratified by Clinical Prognostic Stage and Prognostic Score Category in the two cohorts.

From: A simplified breast cancer prognostic score: comparison with the AJCC clinical prognostic staging system

SEER

UAB

Prognostic stage (N)

DSS (%)

Score category (N)

DSS (%)

Prognostic stage (N)

DSS (%)

Score category (N)

DSS (%)

IA (13,153)

97.2 ± 0.3

I (13,605)

97.2 ± 0.3

IA (2033)

99.5 ± 0.2

I (2155)

99.1 ± 0.5

IB (5821)

94.1 ± 0.7

II (7910)

92.4 ± 0.7

IB (1015)

96.2 ± 0.7

II (1170)

96.4 ± 0.6

IIA (5420)

91.8 ± 0.9

III (7117)

84.9 ± 1.0

IIA (834)

95.2 ± 0.9

III (992)

90.4 ± 1.1

IIB (2774)

83.9 ± 2.7

IV (3234)

68.4 ± 1.9

IIB (482)

88.4 ± 1.8

IV (440)

82.7 ± 2.2

IIIA (1385)

78.3 ± 2.5

V (2240)

47.9 ± 2.4

IIIA (178)

82.1 ± 3.4

V (179)

61.3 ± 4.4

IIIB (3231)

67.9 ± 1.9

VI (1269)

25.5 ± 1.9

IIIB (252)

77.8 ± 3.1

VI (34)

17.2 ± 8.4

IIIC (1032)

43.5 ± 3.3

VII (497)

18.8 ± 3.6

IIIC (92)

52.3 ± 6.3

VII (12)

0

IV (3336)

29.6 ± 1.8

VIII (280)

8.9 ± 3.5

IV (96)

39.4 ± 6.1

VIII (0)

 
  1. DSS disease-specific survival, presented by 95% confidence interval.
Back to article page